Non-steroidal dissociated glucocorticoid agonists: indoles as A-ring mimetics and function-regulating pharmacophores

We report a SAR of non-steroidal glucocorticoid mimetics that utilize indoles as A-ring mimetics. A detailed SAR is discussed with a focus on improving PR and MR selectivity, GR agonism, and in vitro dissociation profile. SAR analysis led to compound ( R)- 33 which showed high PR and MR selectivity,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2011-11, Vol.21 (22), p.6842-6851
Hauptverfasser: Betageri, Raj, Gilmore, Thomas, Kuzmich, Daniel, Kirrane, Thomas M., Bentzien, Jörg, Wiedenmayer, Dieter, Bekkali, Younes, Regan, John, Berry, Angela, Latli, Bachir, Kukulka, Alison J., Fadra, Tazmeen N., Nelson, Richard M., Goldrick, Susan, Zuvela-Jelaska, Ljiljana, Souza, Don, Pelletier, Josephine, Dinallo, Roger, Panzenbeck, Mark, Torcellini, Carol, Lee, Heewon, Pack, Edward, Harcken, Christian, Nabozny, Gerald, Thomson, David S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We report a SAR of non-steroidal glucocorticoid mimetics that utilize indoles as A-ring mimetics. A detailed SAR is discussed with a focus on improving PR and MR selectivity, GR agonism, and in vitro dissociation profile. SAR analysis led to compound ( R)- 33 which showed high PR and MR selectivity, potent agonist activity, and reduced transactivation activity in the MMTV and aromatase assays. The compound is equipotent to prednisolone in the LPS-TNF model of inflammation. In mouse CIA, at 30 mg/kg compound ( R)- 33 inhibited disease progression with an efficacy similar to the 3 mg/kg dose of prednisolone. We report a SAR of non-steroidal glucocorticoid mimetics that utilize indoles as A-ring mimetics. Detailed SAR is discussed with a focus on improving PR and MR selectivity, GR agonism, and in vitro dissociation profile. SAR analysis led to compound ( R)- 33 which showed high PR and MR selectivity, potent agonist activity, and reduced transactivation activity in the MMTV and aromatase assays. The compound is equipotent to prednisolone in the LPS-TNF model of inflammation. In mouse CIA, at 30 mg/kg compound ( R)- 33 inhibited disease progression with an efficacy similar to the 3 mg/kg dose of prednisolone.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2011.09.018